Published:
The Court of Arbitration for Sport (CAS) has overturned Japanese race walker Koki Ikeda’s four-year ban, ruling on October 23, 2026, that he did not commit an anti-doping rule violation. The decision clears the Tokyo Olympic silver medallist to compete again with immediate effect, after an appeal against the sanction imposed by the World Athletics disciplinary process.
Ikeda, who won silver in the men’s 20km race walk at the Tokyo Games held in 2021, had been banned in February 2025 after abnormalities in his Athlete Biological Passport were interpreted as evidence of possible blood manipulation. CAS found that an alternative physiological explanation put forward by Ikeda was plausible, supported by medical and expert evidence.
The appeal panel set aside the original disciplinary decision and concluded that the anti-doping charge had not been established. According to the CAS case summary, the panel accepted that some readings in Ikeda’s biological profile were abnormal, but said the athlete had provided a plausible explanation for those findings. The ruling restores his eligibility to compete immediately.
Ikeda had consistently denied doping. The case was based on abnormalities in the haematological module of his Athlete Biological Passport, which monitors changes in blood-related indicators over time. World Athletics’ anti-doping authorities had argued that the pattern was consistent with blood manipulation, while Ikeda presented medical explanations and expert evidence challenging that interpretation.
CAS said the appeal evidence was more extensive and specific than the material available during the first-instance proceedings. The panel considered submissions, expert opinions and additional documentation before reaching its conclusion. The result is a reversal of the four-year sanction, rather than a reduction in its length.
The Athletics Integrity Unit provisionally suspended Ikeda in November 2024. A four-year sanction was then announced in February 2025, with the original disciplinary ruling also disqualifying results from a specified period beginning in June 2023. Ikeda appealed to CAS in March 2025, disputing the allegation and seeking to have the sanction set aside.
The dispute concerned the interpretation of several blood samples collected in 2023 and the wider biological passport profile. Such a passport is used to identify patterns in an athlete’s biological markers that may warrant investigation; it does not necessarily depend on detecting a specific prohibited substance in a single sample. In this case, the appeal panel concluded that the abnormalities could be explained by a plausible alternative physiological scenario and that the anti-doping violation had not been established.
Ikeda established himself among the world’s leading race walkers before the case. He won silver in the men’s 20km race walk at the Tokyo Olympics, which were staged in 2021, and finished second at the 2022 World Athletics Championships in Eugene, Oregon. He placed seventh in the same event at the Paris 2024 Olympics.
The original ban had interrupted his competitive career and affected results within the period covered by the disciplinary decision. With CAS now overturning the sanction, Ikeda can return to competition. The practical handling of individual results previously disqualified under the original decision should be checked against the full written award and any subsequent updates from the relevant athletics authorities.
The ruling highlights the importance of assessing an athlete’s biological passport alongside the complete medical and expert record. Abnormal readings can trigger anti-doping proceedings, but the panel must determine whether the evidence establishes a violation after considering the athlete’s explanation. CAS found Ikeda’s evidence persuasive enough to overturn the disciplinary finding.
The decision does not mean that biological passport monitoring has no role in anti-doping enforcement. Instead, it reflects the outcome of this individual appeal and the panel’s assessment of the evidence in Ikeda’s case. The full written award will provide the definitive legal reasoning, and any administrative updates to historical results remain a matter for the governing bodies.
Ikeda is immediately eligible to compete again, giving the Japanese race walker the opportunity to resume his career after nearly two years away from competition. His return schedule, upcoming entries and any updates to results affected by the original ban will depend on announcements from Ikeda, his team and the relevant athletics authorities.
For the sport, the decision closes a major chapter in a high-profile case involving a Tokyo Olympic medallist. CAS has set aside the four-year ban and ruled that no period of ineligibility should apply, restoring Ikeda’s right to compete while the full written award remains the authoritative document for the precise legal findings.
